Literature DB >> 23479477

Evaluation of the Healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK.

Benjamin D Hunt1, Stephen L Hiles, Avni Chauhan, Carol Ighofose, Nilesh Bharakhada, Avkash Jain, Melanie J Davies, Kamlesh Khunti.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death globally. Vascular risk assessment is recognized as playing a key role in reducing premature CVD-related morbidity and mortality. The current study evaluated the effectiveness of a pharmacy-led risk assessment service in Leicester City, UK.
METHODS: The vascular risk assessment was offered opportunistically to individuals between 40 and 70 years without any prior diagnosis of CVD on attending their community pharmacist. Individuals were risk stratified using the Framingham score and those classified as high risk were referred to their general practitioner (GP).
RESULTS: Overall, 2521 individuals were recruited from 39 pharmacies consisting of 1059 (42%) males, 1696 (67%) South Asians and 199 (7.9%) individuals not registered with a GP. A total of 462 (18%) individuals were referred to primary care and 52.6% of a representative subset were subsequently recorded as having attended an appointment with their GP; diagnoses and treatments commenced were recorded.
CONCLUSIONS: Cardiovascular risk assessment led by community pharmacies can successfully assess people from large, multi-ethnic UK populations and identify those at high cardiovascular risk or with undiagnosed cardiovascular disease. The service may improve rates of assessments undertaken by individuals who do not access health care through traditional routes.

Entities:  

Keywords:  health services; population-based and preventative services; public health

Mesh:

Year:  2013        PMID: 23479477     DOI: 10.1093/pubmed/fdt017

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  7 in total

1.  Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.

Authors:  Nicole Lowres; Ines Krass; Lis Neubeck; Julie Redfern; Andrew J McLachlan; Alexandra A Bennett; S Ben Freedman
Journal:  Int J Clin Pharm       Date:  2015-07-23

2.  Evaluation of community provision of a preventive cardiovascular programme - the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study.

Authors:  Maria Woringer; Elizabeth Cecil; Hillary Watt; Kiara Chang; Fozia Hamid; Kamlesh Khunti; Elizabeth Dubois; Julie Evason; Azeem Majeed; Michael Soljak
Journal:  BMC Health Serv Res       Date:  2017-06-14       Impact factor: 2.655

3.  A community pharmacy-based cardiovascular risk screening service implemented in Iran.

Authors:  Zahra Jahangard-Rafsanjani; Negar Hakimzadeh; Amir Sarayani; Sheyda Najafi; Kazem Heidari; Mohammad R Javadi; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

4.  Development of a questionnaire to evaluate patients' awareness of cardiovascular disease risk in England's National Health Service Health Check preventive cardiovascular programme.

Authors:  Maria Woringer; Jessica Jones Nielsen; Lara Zibarras; Julie Evason; Angelos P Kassianos; Matthew Harris; Azeem Majeed; Michael Soljak
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

5.  Assessment of pharmacists' knowledge, attitude and practice in chain community pharmacies towards their current function and performance in Indonesia.

Authors:  Umi Athiyah; Catur D Setiawan; Gesnita Nugraheni; Elida Zairina; Wahyu Utami; Andi Hermansyah
Journal:  Pharm Pract (Granada)       Date:  2019-08-24

6.  Influences on individuals' decisions to take up the offer of a health check: a qualitative study.

Authors:  Caroline Burgess; Alison J Wright; Alice S Forster; Hiten Dodhia; Jane Miller; Frances Fuller; Eric Cajeat; Martin C Gulliford
Journal:  Health Expect       Date:  2014-06-03       Impact factor: 3.377

7.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.